VivoSeq
Other

Tobacco

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Tobacco is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

20

clinical trials

Completed16 · 80%
Recruiting2 · 10%
Unknown status1 · 5%
Not yet recruiting1 · 5%

Trial Activity

20 trials

UW Withdraw From Tobacco Study
Completed·UUniversity of Wisconsin, Madison·Phase 2·NCT04969198·232 enrolled
Effects of Nicotine in Tobacco Smokers
Completed·UUniversity of Southern California·Phase 1·NCT03651869·221 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)